Regulation of Insurance with Adverse Selection and Switching Costs: Evidence from Medicare Part D

被引:65
|
作者
Polyakova, Maria [1 ,2 ]
机构
[1] Stanford Univ, Dept Hlth Res & Policy, 150 Governors Lane, Stanford, CA 94305 USA
[2] Natl Bur Econ Res, Cambridge, MA 02138 USA
关键词
PRESCRIPTION DRUG INSURANCE; STATE DEPENDENCE; COVERAGE GAP; CHOICE; WELFARE; ENDOGENEITY; INFORMATION; INERTIA; MARKETS; MODELS;
D O I
10.1257/app.20150004
中图分类号
F [经济];
学科分类号
02 ;
摘要
I take advantage of regulatory and pricing dynamics in Medicare Part D to explore interactions among adverse selection, inertia, and regulation. I first document novel evidence of adverse selection and switching frictions within Part D using detailed administrative data. I then estimate a contract choice and pricing model that quantifies the importance of inertia for-risk sorting. I find that in Part D switching costs help sustain an-adversely-selected equilibrium. I also estimate that active-decision making in the existing policy environment could lead to a substantial gain in annual consumer surplus of on average $400-$600 per capita-20 percent to 30 percent of average annual spending.
引用
收藏
页码:165 / 195
页数:31
相关论文
共 50 条
  • [31] Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review
    Park, Young Joo
    Martin, Erika G.
    HEALTH SERVICES RESEARCH, 2017, 52 (05) : 1685 - 1728
  • [32] How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program
    Brown, Jason
    Duggan, Mark
    Kuziemko, Ilyana
    Woolston, William
    AMERICAN ECONOMIC REVIEW, 2014, 104 (10) : 3335 - 3364
  • [33] Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D
    Einav, Liran
    Finkelstein, Amy
    Polyakova, Maria
    AMERICAN ECONOMIC JOURNAL-ECONOMIC POLICY, 2018, 10 (03) : 122 - 153
  • [34] Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations
    Nattinger, Ann Butler
    Pezzin, Liliana E.
    McGinley, Emily L.
    Charlson, John A.
    Yen, Tina W. F.
    Neuner, Joan M.
    SPRINGERPLUS, 2015, 4
  • [35] Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
    Park, Haesuk
    Rascati, Karen L.
    Lawson, Kenneth A.
    Barner, Jamie C.
    Richards, Kristin M.
    Malone, Daniel C.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (10) : 956 - +
  • [36] Controlling Health Care Costs through Limited Network Insurance Plans: Evidence from Massachusetts State Employees
    Gruber, Jonathan
    McKnight, Robin
    AMERICAN ECONOMIC JOURNAL-ECONOMIC POLICY, 2016, 8 (02) : 219 - 250
  • [37] How Forced Switches Reveal Switching Costs: Evidence from the Loan Market
    Liaudinskas, Karolis
    JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS, 2023, : 3994 - 4034
  • [38] Loan contract structure and adverse selection: Survey evidence from Uganda
    Ahlin, Christian
    Gulesci, Selim
    Madestam, Andreas
    Stryjan, Miri
    JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION, 2020, 172 : 180 - 195
  • [39] Switching motivation and moral hazard: evidence from automobile physical damage insurance in Taiwan
    Liu, Chun-Ting
    Wu, Jui-Yun
    Chang, Chi-Hung
    GENEVA PAPERS ON RISK AND INSURANCE-ISSUES AND PRACTICE, 2020, 45 (02) : 361 - 391
  • [40] Insurers and Lenders as Monitors During Securities Litigation: Evidence from D&O Insurance Premiums, Interest Rates, and Litigation Costs
    Donelson, Dain C.
    Yust, Christopher G.
    JOURNAL OF RISK AND INSURANCE, 2019, 86 (03) : 663 - 696